Novel strategies for the therapy of rheumatoid arthritis

Revmatologiia

Volumn 36, Issue 2, 1997, Pages 265-267

  Hummel, K M ^a   Gay, R E ^a   Gay, S ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; PATHOPHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; HUMANS;

EID: 0031062843     PISSN: 13100505     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.2.265     Document Type: Review

References (6)

1. Muller-Ladner U, Gay RE, Gay S. Structure and function of synoviocytes. In Koopman WJ, ed. Arthritis and allied conditions. A textbook of rheumatology, 13th edn. Baltimore, MD: Williams & Wilkins, pp. 243-54.
2. Muller-Ladner U, Kriegsmann J, Gay RE, Gay S. Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:675-90.
3. Choy EHS, Panayi GS, Kingsley GH. Therapeutic-monoclonal antibodies. Br J Rheumatol 1995;34:707-15.
4. Kalden JR, Manger B. Biologic agents in the treatment of inflammatory rheumatic diseases. Curr Opin Rheumatol 1995;7:191-7.
5. Maini RN, Elliot MJ, Brennan FM, Feldmann M. Beneficial effects of tumour necrosis factor-alpha (TNFα) blockade in rheumatoid arthritis (RA). Clin Exp Immunol 1995;101:207-12.
6. Evans CH, Robbins PD. Pathways to gene therapy in rheumatoid arthritis. Curr Opin Rheumatol 1996;8: 230-4.